Immunovant, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q2 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Immunovant, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q2 2020 to Q1 2024.
  • Immunovant, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending March 31, 2024 was $141K, a 88.7% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $141K -$1.1M -88.7% Mar 31, 2024 10-K 2024-05-29
Q1 2023 $1.25M -$1.22M -49.4% Mar 31, 2023 10-K 2023-05-22
Q1 2022 $2.46M -$1.16M -32% Mar 31, 2022 10-K 2022-06-08
Q1 2021 $3.62M Mar 31, 2021 10-K 2021-06-01
Q4 2020 $3.82M Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $4.12M Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $4.41M Jun 30, 2020 10-Q 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.